FBXO31 determines poor prognosis in esophageal squamous cell carcinoma

International Journal of Oncology

Volumn 39, Issue 1, 2011, Pages 155-159

  Kogo, Ryunosuke ^a,b   Mimori, Koshi ^a   Tanaka, Fumiaki ^a   Komune, Shizuo ^b   Mori, Masaki ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclin D1; Esophageal squamous cell carcinoma; FBXO31

Indexed keywords

CYCLIN D1; FBXO31 PROTEIN; RNA; TUMOR MARKER; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CELL NUCLEUS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOPLASM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

CARCINOMA, SQUAMOUS CELL; CYCLIN D1; ESOPHAGEAL NEOPLASMS; F-BOX PROTEINS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROGNOSIS; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 79956042390     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1018     Document Type: Article

References (26)

1. Enzinger PC and Mayer RJ: Esophageal cancer. N Engl J Med 349: 2241-2252, 2003. (Pubitemid 37485141)
2. Kleinberg L and Forastiere AA: Chemoradiation in the management of esophageal cancer. J Clin Oncol 25: 4110-4117, 2007. (Pubitemid 47492955)
3. Nakamura T, Ota M, Narumiya K, et al: Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol 15: 2451-2457, 2008.
4. Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359: 1727-1733, 2002.
5. Ando N, Iizuka T, Kakegawa T, et al: A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 114: 205-209, 1997. (Pubitemid 27364210)
6. Diehl JA: Cycling to cancer with cyclin D1. Cancer Biol Ther 1: 226-231, 2002.
7. Malumbres M and Barbacid M: To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1: 222-231, 2001. (Pubitemid 33741897)
8. Shinozaki H, Ozawa S, Ando N, et al: Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res 2: 1155-1161, 1996. (Pubitemid 26238446)
9. Nakagawa H, Zukerberg L, Togawa K, Meltzer SJ, Nishihara T and Rustgi AK: Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer 76: 541-549, 1995.
10. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH and Weinstein IB: Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52: 2980-2983, 1992.
11. Jia L and Sun Y: F-box proteins FBXO31 and FBX4 in regulation of cyclin D1 degradation upon DNA damage. Pigment Cell Melanoma Res 22: 518-519, 2009.
12. Kumar R, Neilsen PM, Crawford J, et al: FBXO31 is the chromosome 16q243 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex. Cancer Res 65: 11304-11313, 2005. (Pubitemid 41821687)
13. Shiloh Y: FBXO31: a new player in the ever-expanding DNA damage response orchestra. Sci Signal 2: pe73, 2009.
14. Santra MK, Wajapeyee N and Green MR: F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 459: 722-725, 2009.
15. Enders GH: Cyclins in breast cancer: too much of a good thing. Breast Cancer Res 4: 145-147, 2002.
16. Ogawa K, Utsunomiya T, Mimori K, et al: Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res 11: 2889-2893, 2005. (Pubitemid 40525189)
17. Nishida K, Mine S, Utsunomiya T, et al: Global analysis of altered gene expressions during the process of esophageal squamous cell carcinogenesis in the rat: a study combined with a laser microdissection and a cDNA microarray Cancer Res 65: 401-409, 2005.
18. Quackenbush J: Microarray data normalization and transformation. Nat Genet 32 (Suppl): 496-501, 2002.
19. Brazma A, Hingamp P, Quackenbush J, et al: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29: 365-371, 2001. (Pubitemid 34326681)
20. Venkatraman ES and Olshen AB: A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 23: 657-663, 2007. (Pubitemid 46554715)
21. Gladden AB and Diehl JA: Location, location, location: the role of cyclin D1 nuclear localization in cancer. J Cell Biochem 96: 906-913, 2005. (Pubitemid 41688717)
22. Okabe H, Lee SH, Phuchareon J, Albertson DG, McCormick F and Tetsu O: A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PLoS One 1: e128, 2006.
23. Lin DI, Barbash O, Kumar KG, et al: Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol Cell 24: 355-366, 2006. (Pubitemid 44647901)
24. Barbash O, Zamfirova P, Lin DI, et al: Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 14: 68-78, 2008. (Pubitemid 351885497)
25. Laman H, Funes JM, Ye H, et al: Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. EMBO J 24: 3104-3116, 2005. (Pubitemid 41486346)
26. Wei S, Yang HC, Chuang HC, et al: A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells. J Biol Chem 283: 26759-26770, 2008.